AbCellera Biologics (ABCL US)

AbCellera Biologics Inc. operates as a pharmaceutical company. The Company discovers and develops next generation therapeutic antibodies through combination of technologies including proprietary immunizations, microfluidics, high-throughput imaging, genomics, computation, and laboratory automation. AbCellera Biologics serves customers in Canada.